You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Vancomycin - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for vancomycin and what is the scope of freedom to operate?

Vancomycin is the generic ingredient in seven branded drugs marketed by Xellia Pharms Aps, Ani Pharms, Fresenius Kabi Usa, Lupin Ltd, Orient Pharma Co Ltd, Pai Holdings Pharm, Strides Pharma, Watson Labs, Azurity, Lederle, Alkem Labs Ltd, Amneal, Steriscience, Hikma, Aspiro, Avet Lifesciences, Eugia Pharma, Gland Pharma Ltd, Hainan Poly, Hainan Poly Pharm, Hikma Pharms, Hospira, Hospira Inc, Knack, Meitheal, Mylan Labs Ltd, Pharm Assoc, Sagent Pharms, Sandoz, Sandoz Inc, Teva Pharms Usa, Pharmacia And Upjohn, Samson Medcl, Zhejiang Novus Pharm, and Baxter Hlthcare, and is included in sixty-four NDAs. There are thirteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Vancomycin has forty-seven patent family members in twenty-nine countries.

There are twenty-two drug master file entries for vancomycin.

Summary for vancomycin

International Patents:	47
US Patents:	13
Tradenames:	7
Applicants:	35
NDAs:	64
Drug Master File Entries:	22
Raw Ingredient (Bulk) Api Vendors:	37
Clinical Trials:	423
Patent Applications:	5,720
Drug Prices:	Drug price trends for vancomycin
What excipients (inactive ingredients) are in vancomycin?	vancomycin excipients list
DailyMed Link:	vancomycin at DailyMed

See drug prices for vancomycin

Drug Sales Revenue Trends for vancomycin

See drug sales revenues for vancomycin

Recent Clinical Trials for vancomycin

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Cologne	Phase 2
Heidelberg University	Phase 2
Universitätsmedizin Mannheim	Phase 2

See all vancomycin clinical trials

Pharmacology for vancomycin

Drug Class	Glycopeptide Antibacterial

Anatomical Therapeutic Chemical (ATC) Classes for vancomycin

US Patents and Regulatory Information for vancomycin

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alkem Labs Ltd	VANCOMYCIN HYDROCHLORIDE	vancomycin hydrochloride	FOR SOLUTION;ORAL	214913-002	Nov 14, 2022	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Azurity	FIRVANQ KIT	vancomycin hydrochloride	FOR SOLUTION;ORAL	208910-001	Jan 26, 2018	AB	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Watson Labs	VANCOMYCIN HYDROCHLORIDE	vancomycin hydrochloride	CAPSULE;ORAL	065510-001	Apr 9, 2012		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Xellia Pharms Aps	VANCOMYCIN HYDROCHLORIDE	vancomycin hydrochloride	SOLUTION;INTRAVENOUS	211962-004	Feb 15, 2019		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Hikma	VANCOMYCIN HYDROCHLORIDE	vancomycin hydrochloride	INJECTABLE;INJECTION	062879-001	Aug 2, 1988		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Orient Pharma Co Ltd	VANCOMYCIN HYDROCHLORIDE	vancomycin hydrochloride	CAPSULE;ORAL	210729-002	Apr 29, 2019	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for vancomycin

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Serbia	59851	KOMPOZICIJE GLIKOPEPTIDA (GLYCOPEPTIDE COMPOSITIONS)	⤷ Try a Trial
European Patent Office	4147710	COMPOSITIONS GLYCOPEPTIDIQUES EN SOLUTION (GLYCOPEPTIDE COMPOSITIONS IN SOLUTION)	⤷ Try a Trial
Denmark	3542812		⤷ Try a Trial
Mexico	2017005749	COMPOSICIONES ANTIBIÓTICAS. (GLYCOPEPTIDE COMPOSITIONS.)	⤷ Try a Trial
Chile	2017001139	Composiciones de antibiótico	⤷ Try a Trial
Japan	2020183424	グリコペプチド組成物 (GLYCOPEPTIDE COMPOSITIONS)	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.